For the Inventor, By the Inventor

Enter assignee name

Billerica, MA, United States of America

Emd Lexigen Research Center Corp.

USPTO Granted Patents = 15

CIPO Patents = 1

Forward Citations = 754

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Stephen D Gillies (15 out of 74 patents)

Kin-Ming Lo (9 out of 40 patents)

David A Cheresh (3 out of 27 patents)

4. Ralph A Reisfeld (3 out of 17 patents)

5. Holger N Lode (3 out of 4 patents)

6. Susan Xiuqi Qian (2 out of 13 patents)

7. Yan Lan (2 out of 6 patents)

8. Pascal Andre Stein (1 out of 7 patents)

9. Christa Burger (1 out of 8 patents)

10. Scott Lauder (1 out of 4 patents)

11. John S Wesolowski, Jr (1 out of 3 patents)

12. Kin Ming Lo (1 out of 1 patent)

13. Anita Anne Hamilton (1 out of 19 patents)

14. Yan Lan (0 patent)

15 patents: Sort by Forward Citations

1. 7833976 - Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies (2010-11-16),

2. 7365054 - Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies (2008-04-29),

3. 7323549 - IL-7 fusion proteins (2008-01-29),

4. 7226998 - Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation (2007-06-05),

5. 7186804 - IL-2 fusion proteins with modulated selectivity (2007-03-06),

6. 7169904 - Immunocytokine sequences and uses thereof (2007-01-30),

7. 7148321 - Expression technology for proteins containing a hybrid isotype antibody moiety (2006-12-12),

8. 7141651 - Multiple cytokine protein complexes (2006-11-28),

9. 7115261 - Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies (2006-10-03),

10. 7091321 - Enhancing the circulating half-life of antibody-based fusion proteins (2006-08-15),

11. 7067110 - Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens (2006-06-27),

12. 6992174 - Reducing the immunogenicity of fusion proteins (2006-01-31),

13. 6969517 - Recombinant tumor specific antibody and use thereof (2005-11-29),

14. 6838260 - Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation (2005-01-04),

15. 6617135 - Multiple cytokine protein complexes (2003-09-09),

EMD Lexigen Research Center Corp. is a leading research and development company focused on biotechnology and pharmaceuticals. With a dedication to innovation, we leverage our deep expertise to discover and develop advanced therapies to improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

15 Patents

#41 in Billerica, MA

#1,231 in Massachusetts

#20,443 in US

#38,743 in the World

Billerica, MA, United States of America

Emd Lexigen Research Center Corp.

Forward Citations = 754

13 inventors:

Stephen D Gillies (15 out of 74 patents)

Kin-Ming Lo (9 out of 40 patents)

David A Cheresh (3 out of 27 patents)

4. Ralph A Reisfeld (3 out of 17 patents)

5. Holger N Lode (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…